The contribution of mouse models to understanding the pathogenesis of spinal muscular atrophy.

The contribution of mouse models to understanding the pathogenesis of spinal muscular atrophy.

Spinal muscular atrophy (SMA), which is caused by inactivating mutations in the survival motor neuron 1 (SMN1) gene, is characterized by loss of lower motor neurons in the spinal cord. The gene encoding SMN is very highly conserved in evolution, allowing the disease to be modeled in a range of speci...

Descripció completa

Dades bibliogràfiques
Autors principals:	Sleigh, J, Gillingwater, T, Talbot, K
Format:	Journal article
Idioma:	English
Publicat:	2011

Ítems similars

The contribution of mouse models to understanding the pathogenesis of spinal muscular atrophy
per: James N. Sleigh, et al.
Publicat: (2011-07-01)

Spinal muscular atrophy at the crossroads of basic science and therapy
per: Sleigh, J, et al.
Publicat: (2013)

Spinal muscular atrophy at the crossroads of basic science and therapy.
per: Sleigh, J, et al.
Publicat: (2013)

Pre-symptomatic development of lower motor neuron connectivity in a mouse model of severe spinal muscular atrophy.
per: Murray, L, et al.
Publicat: (2010)

SMN deficiency disrupts brain development in a mouse model of severe spinal muscular atrophy.
per: Wishart, T, et al.
Publicat: (2010)

Spinal muscular atrophy.
per: Talbot, K, et al.
Publicat: (2001)

Alternative splicing events are a late feature of pathology in a mouse model of spinal muscular atrophy.
per: Bäumer, D, et al.
Publicat: (2009)

Development and Translation of Therapies for Spinal Muscular Atrophy
per: Hannah K. Shorrock, et al.
Publicat: (2016-07-01)

Selective vulnerability of motor neurons and dissociation of pre- and post-synaptic pathology at the neuromuscular junction in mouse models of spinal muscular atrophy.
per: Murray, L, et al.
Publicat: (2008)

Review: neuromuscular synaptic vulnerability in motor neurone disease: amyotrophic lateral sclerosis and spinal muscular atrophy.
per: Murray, L, et al.
Publicat: (2010)

Therapeutic strategies for spinal muscular atrophy: SMN and beyond
per: Bowerman, M, et al.
Publicat: (2017)

Therapeutic strategies for spinal muscular atrophy: SMN and beyond
per: Bowerman, M, et al.
Publicat: (2017)

Chapter 16 Spinal Muscular Atrophy
per: Talbot, K, et al.
Publicat: (2003)

Alternative splicing events are a late feature of pathology in a mouse model of spinal muscular atrophy.
per: Dirk Bäumer, et al.
Publicat: (2009-12-01)

Reversible molecular pathology of skeletal muscle in spinal muscular atrophy.
per: Mutsaers, C, et al.
Publicat: (2011)

Therapeutic strategies for spinal muscular atrophy: SMN and beyond
per: Melissa Bowerman, et al.
Publicat: (2017-08-01)

Invertebrate models of spinal muscular atrophy: insights into mechanisms and potential therapeutics.
per: Grice, S, et al.
Publicat: (2011)

Invertebrate models of spinal muscular atrophy: Insights into mechanisms and potential therapeutics
per: Grice, S, et al.
Publicat: (2011)

TDP-43 expression in mouse models of amyotrophic lateral sclerosis and spinal muscular atrophy
per: Turner, B, et al.
Publicat: (2008)

Chondrolectin affects cell survival and neuronal outgrowth in in vitro and in vivo models of spinal muscular atrophy.
per: Sleigh, J, et al.
Publicat: (2014)

TDP-43 expression in mouse models of amyotrophic lateral sclerosis and spinal muscular atrophy
per: Ansorge Olaf, et al.
Publicat: (2008-10-01)

Model systems for exploring new therapeutic interventions and disease mechanisms in spinal muscular atrophies (SMAs)
per: Sleigh, JN
Publicat: (2012)

Bioenergetic status modulates motor neuron vulnerability and pathogenesis in a zebrafish model of spinal muscular atrophy.
per: Penelope J Boyd, et al.
Publicat: (2017-04-01)

Molecular Pathogenesis and New Therapeutic Dimensions for Spinal Muscular Atrophy
per: Andrés López-Cortés, et al.
Publicat: (2022-06-01)

Chapter 7 Spinal muscular atrophies and hereditary motor neuropathies.
per: Talbot, K, et al.
Publicat: (2007)

Spinal Muscular Atrophy
per: J Gordon Millichap
Publicat: (1990-02-01)

Synaptic defects in the spinal and neuromuscular circuitry in a mouse model of spinal muscular atrophy.
per: Karen K Y Ling, et al.
Publicat: (2010-11-01)

Spinal muscular atrophy
per: D'Amico Adele, et al.
Publicat: (2011-11-01)

The altered expression of neurofilament in mouse models and patients with spinal muscular atrophy
per: Charlotte Spicer, et al.
Publicat: (2021-04-01)

Morphological characteristics of motor neurons do not determine their relative susceptibility to degeneration in a mouse model of severe spinal muscular atrophy.
per: Sophie R Thomson, et al.
Publicat: (2012-01-01)

Systemic peptide-mediated oligonucleotide therapy improves long-term survival in spinal muscular atrophy
per: Hammond, S, et al.
Publicat: (2016)

Modeling spinal muscular atrophy in Drosophila.
per: Chang, H, et al.
Publicat: (2008)

Modeling spinal muscular atrophy in Drosophila.
per: Howard Chia-Hao Chang, et al.
Publicat: (2008-09-01)

Spinal Muscular Atrophy and Arthrogryposis
per: J Gordon Millichap
Publicat: (1997-10-01)

Spinal muscular atrophies reveal motor neuron vulnerability to defects in ribonucleoprotein handling.
per: Anderson, K, et al.
Publicat: (2003)

MOLECULAR ANALYSIS OF CHILDHOOD-ONSET SPINAL MUSCULAR-ATROPHY
per: Theodosiou, A, et al.
Publicat: (1995)

Stasimon Contributes to the Loss of Sensory Synapses and Motor Neuron Death in a Mouse Model of Spinal Muscular Atrophy
per: Christian M. Simon, et al.
Publicat: (2019-12-01)

Motor Neuron Gene Therapy: Lessons from Spinal Muscular Atrophy for Amyotrophic Lateral Sclerosis
per: Andrew P. Tosolini, et al.
Publicat: (2017-12-01)

R-Roscovitine Improves Motoneuron Function in Mouse Models for Spinal Muscular Atrophy
per: Rocio Tejero, et al.
Publicat: (2020-02-01)

Recovery of function in a myogenic mouse model of spinal bulbar muscular atrophy
per: Jamie A. Johansen, et al.
Publicat: (2009-04-01)